Cin-107: Clinical Trials

4 trials of Cin-107, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

3 completed, 1 active not recruiting. 4 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	4	Completed 3, Active not recruiting 1

Follow Cin-107: new trials by email Literature Review of Cin-107 trials Research Report on Cin-107

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Parent Study: A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism Sub-study: A Follow-up Substudy After Completion of the BaxPA Main Study. Baxdrostat, Placebo - Primary Hyperaldosteronism	Phase 3	Active not recruiting	AstraZeneca	212	2025-08-07	2026-10-16
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension	Phase 3	Completed	AstraZeneca	326	2024-04-08	2026-04-21
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension Baxdrostat, Placebo - Resistant Hypertension	Phase 3	Completed	AstraZeneca	218	2024-03-01	2026-08-06
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Baxdrostat, Placebo - Uncontrolled Hypertension, Resistant Hypertension	Phase 3	Completed	AstraZeneca	796	2023-11-22	2026-07-30

Conditions studied

Sponsors

Countries

Results publications

NIH funding